NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 8S3A designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
8S3A_NAD_E_1108 | 99% | 58% | 0.045 | 0.981 | 0.64 | 0.96 | - | 3 | 0 | 0 | 100% | 1 |
8S3A_NAD_F_606 | 98% | 56% | 0.052 | 0.976 | 0.72 | 0.98 | 1 | 2 | 0 | 0 | 100% | 1 |
8S3A_NAD_A_608 | 91% | 55% | 0.071 | 0.957 | 0.76 | 0.99 | 1 | 3 | 0 | 0 | 100% | 1 |
8S3A_NAD_C_501 | 73% | 56% | 0.091 | 0.916 | 0.74 | 0.95 | 1 | 5 | 0 | 0 | 100% | 0.89 |
8S3A_NAD_B_501 | 48% | 57% | 0.111 | 0.854 | 0.79 | 0.88 | 1 | 3 | 0 | 0 | 100% | 0.94 |
8S3A_NAD_D_501 | 25% | 55% | 0.144 | 0.778 | 0.8 | 0.95 | 1 | 3 | 4 | 0 | 100% | 0.87 |
8S3D_NAD_E_501 | 100% | 62% | 0.038 | 0.988 | 0.58 | 0.88 | - | 2 | 0 | 0 | 100% | 1 |
8S39_NAD_C_1205 | 96% | 51% | 0.065 | 0.974 | 0.88 | 1.02 | 2 | 2 | 0 | 0 | 100% | 1 |
8S3B_NAD_B_508 | 94% | 59% | 0.065 | 0.963 | 0.71 | 0.87 | 1 | 2 | 0 | 0 | 100% | 1 |
8S38_NAD_C_1407 | 80% | 57% | 0.096 | 0.945 | 0.75 | 0.89 | 1 | 3 | 0 | 0 | 100% | 0.88 |
3CMC_NAD_R_408 | 100% | 20% | 0.016 | 0.998 | 1.63 | 1.74 | 4 | 9 | 0 | 0 | 100% | 1 |
3EC7_NAD_A_400 | 100% | 18% | 0.025 | 0.995 | 1.8 | 1.74 | 5 | 8 | 1 | 0 | 100% | 1 |
4URF_NAD_A_1249 | 100% | 44% | 0.034 | 0.995 | 0.96 | 1.2 | 2 | 4 | 0 | 0 | 100% | 1 |
2C5A_NAD_B_1374 | 100% | 23% | 0.039 | 0.992 | 1.34 | 1.84 | 6 | 7 | 1 | 0 | 100% | 1 |
1HET_NAD_A_402 | 100% | 10% | 0.043 | 0.994 | 2.25 | 2.1 | 9 | 8 | 0 | 0 | 100% | 0.9068 |